The SPIN works in close collaboration with National Representatives, gathering the representatives of the national psoriasis groups who participate to the network. We currently surveying in order to include key opinion leaders on atopic dermatitis at the national level.
SPIN National Representatives are in a privileged position to relay the information about SPIN’s projects, surveys and events at the national level. They have kindly accepted to be the national contact for all kind of collaborations, especially to promote the development of the network’s activities and the exchanges on psoriasis and atopic dermatitis all around the world. Each representative is responsible for the coordination of international collaborations between his or her country and the others, and of course for the participation to the projects around psoriasis and atopic dermatitis at the national level.
SPIN National Representatives will be solicited for input in the organisation of the scientific programme of the SPIN Congress taking place every three years. During the Congress, the National Representatives shall meet to foresee the next Congress and to choose the national or regional group that will be responsible for the scientific organisation of the following Congress.
Please find here below the list of SPIN National Representatives (this list shall be updated regularly):
Aomar AMMAR-KHODJA - Algeria
Graciela Pellerano - Argentina
Pablo FERNÁNDEZ-PEÑAS - Australia
Patrick BRUNNER- Austria
Mohammad SAMIUL HUQ- Bangladesh
Uladzimir ADASKEVICH - Belarus
Michel DE LA BRASSINNE - Belgium
Félix ATADOKPEDE - Benin
Juan Carlos DIEZ DE MEDINA - Bolivia
Asja PROHIC - Bosnia and Herzegovina
Luna AZULAY - Brazil
Nikolai TSANKOV - Bulgaria
Fatou BARRO TRAORE - Burkina Faso
Christine MADENGUE - Cameroon
Chih-ho HONG - Canada
Claudia DE LA CRUZ - Chile
Min ZHENG - China
Chih-Hung LEE - Chinese Taipei
Cesar GONZALEZ A. - Colombia
Laura ALVAREZ MORALES - Costa Rica
Abdoulaye SANGHARE - Cote d’Ivoire
Romana CEOVIC - Croatia
Orestes BLANCO G. - Cuba
Jana HERCOGOVA - Czech Republic
Robert GNIADECKI - Denmark
Lars IVERSEN - Denmark
Alexandra ESPINAL - Dominican Republic
Emad ELGAMAL - Egypt
Leana QUINTANILLA - El Salvador
Jaime MARTINEZ LOPEZ - El Salvador
Külli KINGO- Estonia
Tarja MALKONEN - Finland
Carle PAUL - France
Sophie CONIQUET - Gabon
Nino CHIJAVADZE - Georgia
Tsira LEONIDZE - Georgia
Matthias AUGUSTIN - Germany
Christina ANTONIOU - Greece
Mohamed CISSE - Guinea
Ligia RAMOS - Honduras
Patricia MEJIAS - Honduras
Péter Holló - Hungary
Jon Hjaltalin OLAFSSON - Iceland
Alur S. KUMAR - India
Benny E. WIRYADI- Indonesia
Omid ZARGARI - Iran
Brian KIRBY - Ireland
Lev PAVLOVSKY - Israel
Luigi NALDI - Italy
Hidemi NAKAGAWA - Japan
Laith AKKASH - Jordan
Joo Heung Lee- Korea
Nawaf AL MUTAIRI - Kuwait
Andris RUBINS - Latvia
Abdul Ghani KIBBI - Lebanon
Gamal A. DUWEB - Libya
Skaidra VALIUKEVICIENE - Lithuania
Emilija MANASIEVSKA - Macedonia
Azura Mohd AFFANDI- Malaysia
Ousmane FAYE - Mali
Michael BOFFA - Malta
Mamadou BALL - Mauritania
Boris NEDELCIUC - Moldova
Fatima Zahra MERNISSI- Morocco
Phyllis I. SPULS - Netherlands
Jorge NEIRA - Nicaragua
Ousmane KONATE - Niger
Abel Nze ONUNU - Nigeria
Riad MASHAL - Palestine
Giuliana CASTRO - Peru
Maria Lorna FREZ - Philippines
Jacek SZEPIETOWSKI - Poland
Hugo OLIVEIRA - Portugal
Hassan RIAD - Qatar
George-Sorin TIPLICA - Romania
Nikolay POTEKAEV- Russia
Serge SKREK- Russia
Iqbal A. BUKHARI - Saudi Arabia
Fatimata LY - Senegal
Ljiljana MEDENICA - Serbia
Colin THENG - Singapore
Slavomir URBANCEK - Slovakia
Tomaz LUNDER - Slovenia
Luis PUIG - Spain
Enikö Pivarcsi Sonkoly - Sweden
Antonios Kolios - Switzerland
Fouz HASSAN - Syria
Pravit ASAWANONDA - Thailand
Vincent Pitche - Togo
Nejib DOSS - Tunisia
Mehmet Ali GURER - Turkey
Fayza AL ALI- United Arab Emirates
Christopher GRIFFITHS - United Kingdom
Mark LEBWOHL - United States of America
Oleksandr LITUS - Ukraine
Carlos CARMONA - Uruguay
Erika PAEZ - Venezuela
Alfredo LANDER - Venezuela
Aiman ALSHAMI - Yemen
SPIN Presentation
Recent news
- 2019/10/29 Focus on...
- 2019/08/12 Focus on...
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
Prof Nelida Aurora Raimondo
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action.
J Ethnopharmacol.
2020 Aug 10, 258:112913.
Paeoniae Radix Alba (PRA, called baishao in China), the root of Paeonia lactiflora Pall., has shown a rich medicinal value for more than 2000 years. PRA is used in local medicine and traditional medicine for autoimmune diseases associated with inflammation. At present, total glucosides of paeony (TGP), the main active ingredient of PRA, has been developed into a preparation for the treatment of autoimmune diseases, as TGP exhibits the effect of regulating immunity, anti-inflammatory, and (...)
see on pubmed
Immobilization of papain enzyme on a hybrid support containing zinc oxide nanoparticles and chitosan for clinical applications.
Carbohydr Polym.
2020 Sep 01, 243:116498.
A new hybrid bionanomaterial composed of zinc oxide nanoparticles (ZnO NPs) and chitosan was constructed after enzymatic immobilization of papain for biomedical applications. In this work, we report the preparation and characterization steps of this bionanomaterial and its biocompatibility in vitro. The properties of the immobilized papain system were investigated by transmission electron microscopy, zeta potential, DLS, UV-vis absorption spectroscopy, FTIR spectroscopy, and X-ray (...)
see on pubmed
Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.
Drug Deliv.
2020 Dec , 27, (1):662-680.
Psoriasis is a dermatological chronic skin condition with underlying autoimmune etiology. It deeply affects patients' quality of life. Therefore, it was an interesting target for researchers throughout the past years. Conventionally, the treatment options include anti-inflammatory agents, immune suppressants, biologic treatment, and phototherapy. Nanotechnology offers promising characteristics that allow for tailoring a drug carrier to achieve dermal targeting, improved efficacy and (...)
see on pubmed
on Atopic Dermatitis
The clinical impact of cross-reactions between allergens on allergic skin diseases.
Curr Opin Allergy Clin Immunol.
2020 Aug , 20, (4):374-380.
The route of allergen sensing via the skin appears to influence the immune system towards mounting a type 2 response, especially in genetically predisposed individuals. Allergens recognized this way may derive from microbial, animal, food, or other plant sources and trigger atopic dermatitis. Allergens can be grouped into families depending on their structure and function, harboring significant structural and sequence similarities. Cross-reactivity between allergens is believed to arise as (...)
see on pubmed
Spectral diagnosis of health hazardous toxins in face foundation powders using laser induced breakdown spectroscopy and inductively coupled plasma-optical emission spectroscopy (ICP-OES).
Talanta.
2020 Sep 01, 217:121007.
In this work, we applied laser-induced breakdown spectroscopy (LIBS) to estimate the amount of toxic heavy metals (Pb, Cr, Ni) in five different brands of face foundation powders available in the local market using standard calibration curve (CC)-LIBS approach. These samples contain toxic elements like lead, chromium, nickel which are highly carcinogens to cause eczematous and atopic dermatitis. The strongest atomic transition lines of lead (405.7 line), chromium (425.4 nm line), and nickel (...)
see on pubmed
Update on canine filaggrin: a review.
Combarros D et al.
Update on canine filaggrin: a review.
Vet Q.
2020 Dec , 40, (1):162-168.
Human filaggrin (FLG) plays a key role in epidermal barrier function, and loss-of-function mutations of its gene are primarily responsible for the development of human atopic dermatitis (AD). FLG expression is also reduced in the epidermis of atopic patients, due to the transcriptional effect of Th2 type cytokines. Canine atopic dermatitis (CAD) is a prevalent skin disease that shares many clinical and pathogenic features with its human homologue. The aim of this review is discuss current (...)
see on pubmed
